Towards a cancer mission in Horizon Europe: recommendations | Zendy

Berns Anton | Zendy; Ringborg Ulrik | Zendy; Celis Julio E. | Zendy; Heitor Manuel | Zendy; Aaronson Neil K. | Zendy; AbouZeid Nancy | Zendy; Adami HansOlov | Zendy; Apostolidis Kathi | Zendy; Baumann Michael | Zendy; Bardelli Alberto | Zendy; Bernards René | Zendy; Brandberg Yvonne | Zendy; Caldas Carlos | Zendy; Calvo Fabien | Zendy; Dive Caroline | Zendy; Eggert Angelika | Zendy; Eggermont Alexander | Zendy; Espina Carolina | Zendy; Falkenburg Frederik | Zendy; Foucaud Jérôme | Zendy; Hanahan Douglas | Zendy; Helbig Ulrike | Zendy; Jönsson Bengt | Zendy; Kalager Mette | Zendy; Karjalainen Sakari | Zendy; Kásler Miklós | Zendy; Kearns Pamela | Zendy; Kärre Klas | Zendy; Lacombe Denis | Zendy; Lorenzo Francesco | Zendy; Meunier Françoise | Zendy; Nettekoven Gerd | Zendy; Oberst Simon | Zendy; Nagy Péter | Zendy; Philip Thierry | Zendy; Price Richard | Zendy; Schüz Joachim | Zendy; Solary Eric | Zendy; Strang Peter | Zendy; Tabernero Josep | Zendy; Voest Emile | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Towards a cancer mission in Horizon Europe: recommendations

Author(s) -

Berns Anton,

Ringborg Ulrik,

Celis Julio E.,

Heitor Manuel,

Aaronson Neil K.,

AbouZeid Nancy,

Adami HansOlov,

Apostolidis Kathi,

Baumann Michael,

Bardelli Alberto,

Bernards René,

Brandberg Yvonne,

Caldas Carlos,

Calvo Fabien,

Dive Caroline,

Eggert Angelika,

Eggermont Alexander,

Espina Carolina,

Falkenburg Frederik,

Foucaud Jérôme,

Hanahan Douglas,

Helbig Ulrike,

Jönsson Bengt,

Kalager Mette,

Karjalainen Sakari,

Kásler Miklós,

Kearns Pamela,

Kärre Klas,

Lacombe Denis,

Lorenzo Francesco,

Meunier Françoise,

Nettekoven Gerd,

Oberst Simon,

Nagy Péter,

Philip Thierry,

Price Richard,

Schüz Joachim,

Solary Eric,

Strang Peter,

Tabernero Josep,

Voest Emile

Publication year - 2020

Publication title -

molecular oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.332

H-Index - 88

eISSN - 1878-0261

pISSN - 1574-7891

DOI - 10.1002/1878-0261.12763

Subject(s) - harmonization , translational research , european union , business , health care , portfolio , political science , member states , sustainability , public relations , risk analysis (engineering) , medicine , international trade , ecology , physics , finance , pathology , acoustics , law , biology

A comprehensive cancer approach covering the entire research–care–prevention continuum can achieve a 10‐year cancer‐specific survival for 75% of patients diagnosed in EU member states with well‐developed health care by 2030. To ensure access to a critical mass of patient biological and technological resources, infrastructures for translational research, clinical and prevention trials, and outcomes research are needed. Here, we provide recommendations for achieving key targets and prioritize research areas.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research